Live Breaking News & Updates on Life Sciencesnv Nasdaq|Page 3

Stay updated with breaking news from Life sciencesnv nasdaq. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Investegate |atai Life Sciences Announcements | atai Life Sciences: atai Life Sciences to Participate in October Investor Events & Host Virtual R&D Day

Investegate announcements from atai Life Sciences, atai Life Sciences to Participate in October Investor Events & Host Virtual R&D Day ....

New York , United States , San Francisco , Stephen Bardin , Allan Malievsky , Exchange Commission , Life Sciencesnv Nasdaq , Life Sciences , Life Sciences Virtual Rd Day , October Investor Events , Inaugural Healthcare Opportunities Conference , Roth Inaugural Healthcare Opportunities , Psychiatry Conference , Cantor Fitzgerald , Private Securities Litigation Reform Act , Annual Report , Investegate Announcements , Investegate Company Announcements , Atai Life Sciences , Lobenewswire And Globenewswire ,

Investegate |atai Life Sciences Announcements | atai Life Sciences: atai Life Sciences to Participate in September Investor Events

Investegate announcements from atai Life Sciences, atai Life Sciences to Participate in September Investor Events ....

New York , United States , Stephen Bardin , Allan Malievsky , Exchange Commission , Industry Panel , Life Sciencesnv Nasdaq , Life Sciences , Company Presentation , September Investor , Annual Biopharma Conference , Annual Global Investment Conference , Annual Novel Mechanisms , Neuropsychiatry Virtual , Emerging Novel Treatments , Mental Health Summit , Private Securities Litigation Reform Act , Annual Report , Financial Officer , External Affairs , Investegate Announcements , Investegate Company Announcements , Atai Life Sciences , Lobenewswire And Globenewswire ,

atai Life Sciences to Participate in September Investor Events

NEW YORK and BERLIN, Sept. 07, 2022 (GLOBE NEWSWIRE) atai Life Sciences N.V. (Nasdaq: ATAI) ("atai"), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders ....

New York , United States , Stephen Bardin , Allan Malievsky , Exchange Commission , Industry Panel , Life Sciencesnv Nasdaq , Life Sciences , Company Presentation , Annual Biopharma Conference , Annual Global Investment Conference , Annual Novel Mechanisms , Neuropsychiatry Virtual , Emerging Novel Treatments , Mental Health Summit , Private Securities Litigation Reform Act , Annual Report , Financial Officer , External Affairs ,

Investegate |atai Life Sciences Announcements | atai Life Sciences: atai Life Sciences Reports Second Quarter 2022 Financial Results & Business Update

Investegate announcements from atai Life Sciences, atai Life Sciences Reports Second Quarter 2022 Financial Results & Business Update ....

Chad Beyer , Kabir Nath , Stephen Bardin , Mario Saltarelli , Srinivas Rao , Allan Malievsky , Global Pharmaceuticals At Otsuka , Team Expansion , Life Sciences Reports Second Quarter , Recognify Life Sciences , Exchange Commission , Life Sciencesnv Nasdaq , Viridia Life Sciences , Life Sciences , Securities Exchange , Hercules Capital Inc , Florian Brand , Chief Executive Officer , Chief Scientific Officer , Founder Florian Brand , Founder Srinivas Rao , Treatment Resistant Depression , Anorexia Nervosa , Senior Managing Director , Global Pharmaceuticals , Cognitive Impairment Associated ,

atai Life Sciences Secures Term Loan Facility for up to $175 Million from Hercules Capital

- Non-dilutive financing facility, plus $312M existing cash on hand as of June 30, 2022, gives atai access to up to $487M to continue developing next generation mental health treatments -. | August 15, 2022 ....

Michael Dutra , Stephen Bardin , Janice Bourque , Latham Watkins , Allan Malievsky , Morrison Foerster Llp , Exchange Commission , Life Sciencesnv Nasdaq , Life Sciences , Securities Exchange , Hercules Capital Inc , Morrison Foerster , Hercules Capital , Florian Brand , Chief Executive Officer , Managing Director , Current Report , Private Securities Litigation Reform Act , Securities Act , Securities Exchange Act , Annual Report , External Affairs , Atai Life Sciencesnv Stock Exchange , Press Release , Reatments Atai Nl0015000dx5 ,